Magnitude and management of hypercholesterolemia in the adult population of Spain, 2008-2010: The ENRICA study;Magnitud y manejo de la hipercolesterolemia en la población adulta de España, 2008-2010: el estudio ENRICA

Revista Espanola de Cardiologia

Volumn 65, Issue 6, 2012, Pages 551-558

  Guallar Castillón, Pilar ^a,b   Gil Montero, Miriam ^a,c   León Muñoz, Luz M ^a,b   Graciani, Auxiliadora ^a,b   Bayán Bravo, Ana ^a   Taboada, José M ^d   Banegas, José R ^a,b   Rodríguez Artalejo, Fernando ^a,b  

^a AUTONOMOUS UNIVERSITY OF MADRID   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c HOSPITAL RAMÓN Y CAJAL   (Spain)

^d Centro de Investigation Basica Sanofi Aventis   (Spain)

Author keywords

Epidemiology; High density lipoproteins; Hypercholesterolemia; Hyperlipoproteinemia; Low density lipoproteins; Population

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; AGED; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES MELLITUS; DISEASE CONTROL; DISEASE SEVERITY; DYSLIPIDEMIA; FEMALE; GENDER; HIGH RISK PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; REVIEW; SEX DIFFERENCE; SPAIN;

EID: 84861230127     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2012.02.005     Document Type: Article

References (36)

1. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-97.
2. C. Baigent, A. Keech, P.M. Kearney, L. Blackwell, G. Buck, and C. Pollicino Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins Lancet 366 2005 1267 1278
3. J. Stamler, M.L. Daviglus, D.B. Garside, A.R. Dyer, P. Greenland, and J.D. Neaton Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity JAMA 284 2000 311 318 (Pubitemid 30469857)
4. W.M. Verschuren, D.R. Jacobs, B.P. Bloemberg, D. Kromhout, A. Menotti, and C. Aravanis Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study JAMA 274 1995 131 136
5. A.L. Catapano, Z. Reiner, G. De Backer, I. Graham, M.R. Taskinen, and O. Wiklund ESC/EAS Guidelines for the management of dyslipidaemias. The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) Atherosclerosis 217 2011 3 46
6. A. Keys Seven countries 1980 Cambridge University Press Cambridge p. 315-43
7. K. Kuulasmaa, H. Tunstall-Pedoe, A. Dobson, S. Fortmann, S. Sans, and H. Tolonen Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations Lancet 355 2000 675 687 (Pubitemid 30107623)
8. G. Flores-Mateo, M. Grau, M. O'Flaherty, R. Ramos, R. Elosua, and C. Violan-Fors Análisis de la disminución de la mortalidad por enfermedad coronaria en una población mediterránea: España 1988-2005 Rev Esp Cardiol 64 2011 988 996
9. F. Rodríguez-Artalejo, P. Guallar-Castillón, F. Villar, and J.R. Banegas Critical review and proposals for improvement of the health information systems on cardiovascular diseases in Spain Med Clin (Barc) 131 2008 302 311
10. J. He, D. Gu, K. Reynolds, X. Wu, P. Muntner, and J. Zhao Serum total and lipoprotein cholesterol levels and awareness, treatment, and control of hypercholesterolemia in China Circulation 110 2004 405 411 (Pubitemid 38993849)
11. M.D. Carroll, D.A. Lacher, P.D. Sorlie, J.I. Cleeman, D.J. Gordon, and M. Wolz Trends in serum lipids and lipoproteins of adults, 1960-2002 JAMA 294 2005 1773 1781 (Pubitemid 41434623)
12. P. Primatesta, and N.R. Poulter Levels of dyslipidaemia and improvement in its management in England: results from the Health Survey for England 2003 Clin Endocrinol (Oxf) 64 2006 292 298
13. M.D. Carroll, D.A. Lacher, M. Wolz, and P.D. Sorlie 30-year trends in serum lipids among United States adults: results from the national health and nutrition examination surveys II, III, and 1999-2006 Am J Cardiol 107 2011 1868 1870
14. Centers for Disease Control, Prevention Vital signs: prevalence, treatment, and control of high levels of low-density lipoprotein cholesterol - United States, 1999-2002 and 2005-200 MMWR Morb Mortal Wkly Rep 60 2011 109 114
15. G.A. Roth, S.D. Fihn, A.H. Mokdad, W. Aekplakorn, T. Hasegawa, and S.S. Lim High total serum cholesterol, medication coverage and therapeutic control: an analysis of national health examination survey data from eight countries Bull World Health Organ 89 2011 92 101
16. M. Miller, N.J. Stone, C. Ballantyne, V. Bittner, M.H. Criqui, and H.N. Ginsberg Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association Circulation 123 2011 2292 2333
17. J.R. Banegas, F. Villar-Alvarez, C. Pérez, R. Jiménez, E. Gil, and J. Muñiz Estudio epidemiológico de los factores de riesgo cardiovascular en la población española de 35 a 64 años Rev San Hig Pub 67 1993 419 445
18. DRECE study group J.A. Gomez-Gerique, J.A. Gutierrez-Fuentes, M.T. Montoya, A. Porres, A. Rueda, and A. Avellaneda Lipid profile of the Spanish population: the DRECE (diet and risk of cardiovascular disease in Spain) study Med Clin (Barc) 113 1999 730 735
19. R. Gabriel, M. Alonso, A. Segura, M.J. Tormo, L.M. Artigao, and J.R. Banegas Prevalencia, distribución y variabilidad geográfica de los principales factores de riesgo cardiovascular en España. Análisis agrupado de datos individuales de estudios epidemiológicos poblacionales: estudio ERICE Rev Esp Cardiol 61 2008 1030 1040
20. M. Grau, R. Elosua, A. Cabrera de León, M.J. Guembe, J.M. Baena-Díez, and T. Vega Alonso Factores de riesgo cardiovascular en España en la primera década del siglo xxi: análisis agrupado con datos individuales de 11 estudios de base poblacional, estudio DARIOS Rev Esp Cardiol 64 2011 295 304
21. F. Rodríguez-Artalejo, A. Graciani, P. Guallar-Castillón, L.M. León-Muñoz, M.C. Zuluaga, and E. Lopez-Garcia Justificación y métodos del estudio sobre nutrición y riesgo cardiovascular en España (ENRICA) Rev Esp Cardiol 64 2011 876 882
22. A. Aromaa, P. Koponen, J. Tafforeau, and C. Vermeire Evaluation of health interview surveys and health examination surveys in the European Union Eur J Public Health 13 Suppl 3 2003 67 72 (Pubitemid 37158448)
23. W.T. Friedewald, R.I. Levy, and D.S. Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin Chem 18 1972 499 502
24. I. Graham, D. Atar, K. Borch-Johnsen, G. Boysen, G. Burell, and R. Cifkova European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts) Eur J Cardiovasc Prev Rehabil 14 Suppl 2 2007 E1 E40
25. A. Maiques Galán, C. Brotons-Cuixart, F. Villar-Alvarez, F. Lobos-Bejarano, J. Torcal-Laguna, and D. Orozco-Beltrán Recomendaciones preventivas cardiovasculares PAPPS de 2009. Programa de actividades preventivas y de promoción de la salud. Sociedad Española de Medicina de Familia y Comunitaria 2009 semFYC Barcelona p. 101-13
26. J.M. Lobos, M.A. Royo-Bordonada, C. Brotons, L. Alvarez-Sala, P. Armario, and A. Maiques European Guidelines on Cardiovascular Disease Prevention in Clinical Practice: CEIPC 2008 Spanish adaptation Rev Esp Salud Publica 82 2008 581 616
27. J.L. Gutiérrez-Fisac, P. Guallar-Castillón, L.M. León-Muñoz, A. Graciani, J.R. Banegas, and F. Rodríguez- Artalejo Prevalence of general and abdominal obesity in the adult population of Spain, 2008-2010: the ENRICA study Obes Rev 2011 10.1111/j.1467-789X.2011.00964. x
28. J.R. Banegas, F. Rodríguez-Artalejo, L.M. Ruilope, A. Graciani, M. Luque, and J.J. De la Cruz-Troca Hypertension magnitude and management in the elderly population of Spain J Hypertens 20 2002 2157 2164 (Pubitemid 35388233)
29. Standards of medical care in diabetes - 2012. Diabetes Care. 2012;35 Suppl 1:S11-63.
30. E.S. Ford, C. Li, W.S. Pearson, G. Zhao, and A.H. Mokdad Trends in hypercholesterolemia, treatment and control among United States adults Int J Cardiol 140 2010 226 235
31. V.L. Roger, A.S. Go, D.M. Lloyd-Jones, E.J. Benjamin, J.D. Berry, and W.B. Borden Heart disease and stroke statistics - 2012 Update: a report from the American Heart Association Circulation 125 2012 e2 e220
32. J. Muller-Nordhorn, S. Binting, S. Roll, and S.N. Willich An update on regional variation in cardiovascular mortality within Europe Eur Heart J 29 2008 1316 1326 (Pubitemid 351768126)
33. R. Masia, A. Pena, J. Marrugat, J. Sala, J. Vila, and M. Pavesi High prevalence of cardiovascular risk factors in Gerona, Spain, a province with low myocardial infarction incidence. REGICOR Investigators J Epidemiol Community Health 52 1998 707 715 (Pubitemid 28491029)
34. A. Bach-Faig, C. Fuentes-Bol, D. Ramos, J.L. Carrasco, B. Roman, and I.F. Bertomeu The Mediterranean diet in Spain: adherence trends during the past two decades using the Mediterranean Adequacy Index Public Health Nutr 14 2011 622 628
35. C.M. Meseguer, I. Galan, R. Herruzo, and F. Rodriguez-Artalejo Tendencias de actividad física en tiempo libre y en el trabajo en la Comunidad de Madrid, 1995-2008 Rev Esp Cardiol 64 2011 21 27
36. S. Singh How can chronic disease management programmes operate across care settings and providers? 2008 World Health Organization, on behalf of the European Observatory on Health Systems and Policies Copenhague p. 1-17